Ott Group Creates Ethos Biosciences in Philadelphia, Pennsylvania
11/20/2018
"This new business gives us the capability to design and develop diagnostics, as well as specialty reagents to meet the growing demands of our customers," said Michael H. Ott, President & CEO of The Ott Group. "The products and services that Ethos provides will be offered through the broad distribution of our sister companies, and it will address a new segment of the industry for us."
In conjunction, Ethos Biosciences has acquired the Exocell product line from Glycadia Pharmaceuticals. Ethos Biosciences will assume the laboratory and office space of the former Glycadia diagnostic unit at 1880 JFK Boulevard in Philadelphia. Exocell products have served the scientific community for more than 30 years as trusted, easy-to-use diagnostics and reagents, company officials said. Primarily used in experimental and clinical research of diabetes and associated kidney and vascular diseases, Exocell offers products targeting albumin, glycated albumin, creatinine, nephrin, collagen and hemoglobin, among many others.
"Ethos will continue to provide the excellent products that our customers expect while building our product offerings," said Ryan Ott, President of Ethos Biosciences. "We also look forward to providing custom development of reagents and diagnostic test kits to help our customers meet their research and clinical goals. The expertise of our scientific staff at Ethos is incredible with more than 100 scientific publications and dozens of patent applications. We intend to build upon the legacy of the Exocell brand."
The Ott Group is a family owned and operated holding company of specialty chemical manufacturing and related companies, which includes Polysciences, Inc., Bangs Laboratories, Inc., Astral Diagnostics, Inc., Creative Consumer Products, Inc., Polysciences GmbH, Polysciences Asia-Pacific, Inc.
Project Announcements
Little Leaf Farms Plans Coffee County, Tennessee, Production Operations
07/02/2025
White Rock Truss & Components Expands Lee County, Virginia, Operations
07/02/2025
Fox Tank Company Plans Coshocton, Ohio, Operations
07/02/2025
Ascentek Expands Shreveport, Louisiana, Operations
07/02/2025
ProBio Establishes Hopewell, New Jersey, Gene Therapy Operations
07/02/2025
22nd Century Technologies Expands Fairfax County, Virginia, Headquarters Operations
07/02/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
First Person: David Robey, Co-CEO of QTS Data Centers
Q2 2025